Jordanides et al. detected 6.8-fold higher BCRP mRNA expression in CD34+ cells derived from chronic myeloid leukemia patients than normal CD34+ cells [104]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.